Clinical Trial Update: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing optimal loading dose and antiplatelet strategy for clopidogrel in acute coronary syndrome and unstable angina has completed and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Unstable Angina

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Sanofi | Conditions: Acute Coronary Disease, Angina Unstable | Phase 3 | Status: COMPLETED | Results posted: 2010-10-07